Novartis Pharmaceuticals Canada Inc. head office building in Dorval, Quebec, Canada.

JHVEPhoto/iStock Editorial via Getty Images

Novartis (NVS) shares fell in Zurich on Thursday after the Swiss drugmaker updated its mid-term guidance, indicating a 5% compound annual growth rate for net sales from 2026 to 2031 on a forex-adjusted basis.

The revised outlook fell short of

Source link

Leave a Reply

Discover more from Occasional Digest

Subscribe now to keep reading and get access to the full archive.

Continue reading